AstraZeneca

Geneva: A causal link between the AstraZeneca Covid-19 vaccine and the rare occurrence of blood clots with low platelets is "considered plausible but not confirmed," the World Health…

London: In the wake of several European countries suspending the use of the AstraZeneca Covid-19 vaccine, the company has said that there has been no evidence of increased blood clot risk…

Geneva: Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), said that the UN health agency "systematically reviews safety signals, and is carefully assessing…

Kathmandu: Nepal on Sunday received the one million doses of Covishield vaccine it bought from India's Serum Institute, in a major boost to the country's fight against the COVID-19 pandemic.…

New Delhi: India has crossed a significant milestone in immunisation against Covid-19 with than 10 million people having been vaccinated, as of Friday, officials said. "In the fight…

London: The Oxford-AstraZeneca's Covid-19 vaccine showed 76 per cent efficacy against symptomatic infection for three months after a single dose, with protection maintained to the second…

New Delhi: Pune-based Serum Institute of India on Monday expressed hope at the possibility of Covid-19 vaccine - Covishield receiving the regulatory approval in "few days", while emphasising…

New Delhi: Serum Institute of India, which has partnered with AstraZeneca to manufacture the Oxford-AstraZeneca vaccine, said on Saturday that the country would require a massive funding of…

London: The Oxford University and AstraZeneca COVID-19 vaccine is set to be used for a mix and match trial with Russia's Sputnik vaccine against the novel coronavirus. The two sets of…

New Delhi: After Sputnik V vaccines clinical trial's preliminary results showed its efficacy at above 90 percent, the Russian Direct Investment Fund and Gamaleya Institute offered…